Nebulizer Devices Market Report
The report on the Global Nebulizer Devices Market is segmented by Type (Jet, Ultrasound, Mesh), By End-Use (Hospital and clinics, Emergency Centers, Home Healthcare), and Region. It also focuses on the COVID-19 Impact Analysis and Forecast to 2026.
This market research report provides in-depth information on trends, dynamics, revenue opportunities, competitive landscape, and recent developments in the global Nebulizer Devices Market. The historic years considered for the study are 2016-2019, the base year is 2020, the estimated year is 2021, and the forecast period is 2022-2026.
The report on the Global Nebulizer Devices Market is segmented by Type (Jet, Ultrasound, Mesh), By End-Use (Hospital and clinics, Emergency Centers, Home Healthcare), and Region. It also focuses on the COVID-19 Impact Analysis and Forecast to 2026....
Covid-19 has impacted the market dynamics, competition, and global supply chain. The revenues have gone down in 2020 and may resume an uptrend gradually from 2021. Companies optimizing their operation and strategy will sustain and beat the competition.
Note: The summary below might not have included insights on covid impact since we have large number of reports.
The Global Nebulizer Devices Market is projected to grow from USD 940.5 million in 2020 to USD 1,430.2 million by 2026 at a CAGR of over 7.2% during the forecast period.
Figure: Global Nebulizer Devices Market Size, 2020-2026 (USD Million)
To learn more about this report, Click here.
Nebulizers are respiratory drug delivery therapeutic device that helps to transform the liquid drug into aerosols or mist and delivers it directly to lungs. The technique of nebulization is commonly used for the treatment of respiratory diseases such as cystic fibrosis, asthma, and chronic obstructive pulmonary disease (COPD). These devices are electrically powered and rechargeable. Nebulizers are specifically used for the delivery of liquid medication to breathing passage, thus reduce the bulging of the mucous membrane caused by pollutants.
Key players operating in the global nebulizer devices market are-
A rise in environmental pollution and a surge in the number of smokers propel the need for nebulizer devices.
Based on type, the global nebulizer devices market has been categorized into jet, ultrasound, and mesh.
By region, the North American market garnered the highest market share of almost 38% in 2020 and is projected to grow at a steady CAGR during the assessment period.
This is mainly attributed to the rising respiratory disorders, well-established healthcare infrastructure, rise in customer awareness, and government initiatives such as favorable reimbursement scenario, further accelerates the regional market growth.
The unprecedented outbreak of COVID-19 resulted in surging demand for mechanical ventilators, thus created a substantial shortage of these devices in major COVID-19 affected countries.
The unmet demand for mechanical ventilators is encouraging medical professionals to shift towards other respirator devices such as nebulizers and oxygen concentrators. Thus, this acts as a key factor positively influencing the product demand in the present period.
Want to know the full scope of the report? Register Here
Here is the list of the group of customers that the Nebulizer device market hopes to have the greatest opportunity to convert-
Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at [email protected].
The nebulizer devices market size is expected to reach USD 1,430.2 million in the foreseeable future.
Agilent Technologies, Inc. (The U.S), Allied Healthcare Products, Inc. (The U.S), CareFusion Corporation (The U.S), Covidien plc (Ireland), GE Healthcare (The U.S), GF Health Products Inc. (The U.S), Omron Healthcare, Inc. (Japan), PARI GmbH (Germany), Koninklijke Philips N.V. (Netherlands) and Briggs Healthcare (The U.S) are among the key players in the nebulizer devices market.
The nebulizer devices market is expected to grow at an impressive CAGR of 7.2% in the coming years.
North America garnered the highest share in nebulizer devices market in 2020.
The mesh segment is expected to grow at the fastest CAGR in the nebulizer devices market in the coming years.
A rise in environmental pollution and a surge in the number of smokers, rising of chronic respiratory diseases, the growing geriatric population, and increasing demand for home-based healthcare devices are the factors driving the growth of nebulizer devices market.
Nebulizer devices companies, Hospitals, R&D organizations, Respiratory devices manufacturing companies, Government organizations are the target audience in the nebulizer market.